Immix Biopharma (IMMX) vs Lexicon Pharmaceuticals (LXRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Immix Biopharma (IMMX) has outperformed Lexicon Pharmaceuticals (LXRX) over the past year, gaining 278.1% versus a gain of 15.8%. Immix Biopharma is the larger company by market cap ($786.7 million vs $783.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IMMX | LXRX |
|---|---|---|
| Share price | $9.49 | $1.76 |
| Market cap | $786.75M | $783.12M |
| 1-day change | -1.56% | +0.57% |
| YTD return | +81.45% | +53.04% |
| 1-year return | +278.09% | +15.79% |
| 5-year return | — | -71.43% |
| EPS (TTM) | $-0.88 | $-0.16 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.10 | $2.68 |
| 52-week low | $2.31 | $1.10 |
| Distance from 52-week high | -37.15% | -34.33% |
| Average volume | 1.66M | 2.91M |
| Shares outstanding | 82.90M | 444.96M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IMMX has outperformed LXRX by 262.3 percentage points over the past year.
IMMX vs LXRX FAQ
Which is bigger, Immix Biopharma or Lexicon Pharmaceuticals?
Immix Biopharma (IMMX) is larger, with a market capitalization of $786.75M compared with $783.12M for Lexicon Pharmaceuticals (LXRX).
Which stock has performed better over the past year, IMMX or LXRX?
IMMX returned +278.09% over the past 12 months, compared with +15.79% for LXRX (price return, excluding dividends). Past performance does not predict future results.
Are Immix Biopharma and Lexicon Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.